vimarsana.com
Home
Live Updates
Dr Aldoss on the Use of Revumenib in KMT2A-Rearranged Acute Leukemia : vimarsana.com
Dr Aldoss on the Use of Revumenib in KMT2A-Rearranged Acute Leukemia
Ibrahim T. Aldoss, MD, discusses the use of revumenib monotherapy in patients with relapsed/refractory acute leukemia harboring KMT2A rearrangements.
Related Keywords
Ibrahimt Aldoss ,
,
Department Of Hematology Hematopoietic Cell Transplantation ,
Division Of Leukemia ,
Hematopoietic Cell Transplantation ,
Hematologic Oncology ,
Onclive Tv ,
City Of Hope ,
vimarsana.com © 2020. All Rights Reserved.